Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy
Cancer vaccines have been extensively studied in recent years and have contributed to exceptional achievements in cancer treatment. They are some of the most newly developed vaccines, although only two are currently approved for use, Provenge and Talimogene laherparepvec (T-VEC). Despite the approva...
Main Authors: | Yingxuan Zhang, Zheyan Fang, Ruizhen Li, Xiaotian Huang, Qiong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1314 |
Similar Items
-
Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
by: Kuang Tan, et al.
Published: (2018-04-01) -
Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine Potency
by: Elena Palmieri, et al.
Published: (2021-03-01) -
Outer Membrane Vesicle Vaccines from Biosafe Surrogates Prevent Acute Lethal Glanders in Mice
by: Michael H. Norris, et al.
Published: (2018-01-01) -
<i>Yersinia</i> Outer Membrane Vesicles as Potential Vaccine Candidates in Protecting against Plague
by: Andrey A. Byvalov, et al.
Published: (2020-12-01) -
Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection
by: Zifan Song, et al.
Published: (2020-06-01)